Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide long-term clinical safety and efficacy data for
tenofovir disoproxil fumarate and emtricitabine in HIV-infected patients experiencing various
degrees of renal impairment.
Phase:
Phase 4
Details
Lead Sponsor:
Gilead Sciences
Treatments:
Emtricitabine Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Tenofovir